8
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T2679 | BMS-265246 | BMS265246 | CDK |
BMS-265246 is a potent and selective CDK1/2 inhibitor. | |||
T8498 | EIDD-1931 | Beta-d-N4-hydroxycytidine | Virus Protease , HCV Protease , SARS-CoV , Topoisomerase |
EIDD-1931 (Beta-d-N4-hydroxycytidine) is a ribonucleoside analog with antiviral activity.It inhibits replication of severe acute respiratory syndrome coronavirus (SARS-CoV) in Vero 76 cells, Middle East respiratory syndr... | |||
T79245 | SARS-CoV-2-IN-45 | SARS-CoV | |
SARS-CoV-2-IN-45 (Compound 8p) serves as an inhibitor of SARS-CoV-2, effectively hindering viral replication in Calu-3 cells with an EC50 value of 0.5 μM and exhibiting negligible cytotoxic effects [1]. | |||
T81206 | SARS-CoV-2-IN-65 | SARS-CoV | |
SARS-CoV-2-IN-65 (compound 2f (81)) is a potent, orally active reversible inhibitor of SARS-CoV-2 entry, primarily obstructing the RBD:ACE2 interaction and TMPRSS2 activity within the ACE2-dependent pathway in Calu-3 cel... | |||
T81209 | SARS-CoV-2-IN-62 | SARS-CoV | |
SARS-CoV-2-IN-62 (Compound R3b) effectively inhibits SARS-CoV-2 replication in Vero E6 and Calu-3 cells, demonstrating low cytotoxicity and EC50 values of 2.97 μM and 3.82 μM, respectively [1]. | |||
T79244 | SARS-CoV-2-IN-44 | SARS-CoV | |
SARS-CoV-2-IN-44, an inhibitor of SARS-CoV-2, effectively suppresses viral replication with an EC50 value of 0.6μM and exhibits negligible cytotoxicity in Calu-3 cells, rendering it suitable for antiviral research [1]. | |||
T81208 | SARS-CoV-2-IN-63 | SARS-CoV | |
SARS-CoV-2-IN-63 (Compound R3e) serves as an inhibitor of SARS-CoV-2 replication, demonstrating low cytotoxicity. It effectively suppresses viral replication within Vero E6 cells and Calu-3 cells, yielding half-maximal e... | |||
T69035 | Camostat free base | ||
Camostat, also known as FOY 305, is a serine protease inhibitor. Camostat is used in the treatment of some forms of cancer and is also effective against some viral infections, as well as inhibiting fibrosis in liver or... |